Q1 2022 Holdings
Filed 2022-05-16 | 21 holdings | $20.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $10.1M | 150,000 | 50.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.8M | 1,309,430 | 49.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $15.8K | 285,000 | 0.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $10.9K | 650,000 | 0.1% |
| Guardant Health Inc(GH) | COM | 40131M109 | $10.6K | 160,000 | 0.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $9.2K | 496,012 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $7.0K | 181,500 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $6.0K | 1,137,152 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $6.0K | 170,000 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $5.9K | 735,000 | 0.0% |
| Isoplexis Corp | COM | 465005106 | $5.7K | 1,650,118 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $4.8K | 699,664 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $4.7K | 1,080,566 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $4.4K | 60,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $4.0K | 3,364,895 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.9K | 450,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $3.7K | 550,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.7K | 175,000 | 0.0% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $3.6K | 314,804 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $2.8K | 2,920,780 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $2.4K | 105,360 | 0.0% |